Life sciences webinar

Bridging the digital divide for improved patient diversity

Watch this Reuters Events webinar on demand to learn more about fostering diversity in decentralized clinical trials

Huma’s Chief Medical Officer (R&D) Dr Mert Aral joined industry experts to discuss:

  • How to prioritise factors when designing diverse clinical trials
  • Decentralised, Hybrid or Traditional trials? Best practices that help break down the digital divide for diverse enrolment
  • How to embody diversity in trial design: co-creation with patients on trial design, limiting exclusion factors, identifying novel endpoints and operational factors.
  • Building diversity accountability: develop meaningful KPIs to drive internal culture change

Register here to watch on demand 



More about the speakers

Dr Mert Aral Chief Medical Officer (R&D), Huma
Jasna Tholens Global Director Clinical Trial Management, Johnson & Johnson
LaShell Robinson Director, Diversity & Inclusion in Clinical Trials, Takeda Pharmaceuticals
Michael Zaiac Head of Medical Affairs, Oncology Region Europe, Novartis
Craig Lipset Advisor and Founder of Clinical Innovation Partners (Chair)